Purpose: To report the frequency and predictors of presenting seizures in cerebral venous sinus thrombosis (CVST) and their influence on seizure recurrence and outcome. Methods: This retrospective study, between 1995 and 2011, included 90 consecutive patients with CVST diagnosed using magnetic resonance imaging (MRI) and magnetic resonance venography (MRV). Clinical parameters like frequency, type (presenting, early, and late), and duration of seizures, precipitating causes of CVST, and underlying prothrombotic conditions, were recorded. The location of infarction on MRI and the number of sinuses involved on MRV, were noted. The patients were prescribed anticoagulants, and those with seizures were prescribed antiepileptic drugs. The patients were followed up at 3, 6, and 12 months. The functional outcome at 6 months was categorized into death, poor, partial and complete recovery. Results: A total of 42 patients with CVST presented with seizures (focal 11, focal with secondary generalized 19, and generalized tonic clonic 16), of whom 10 had status epilepticus. On univariate analysis, supratentorial lesion (P = 0.005), frontal (P = 0.02) or parietal lobe (P = 0.04) involvement and haemorrhagic lesion (P = 0.002) were associated with higher risk of presenting seizure. On multivariate analysis, only supratentorial parenchymal lesion on MRI (odds ratio [OR] = 4.67, 95% confidence interval [CI] 1.51-15.08, P = 0.005) was independently associated with higher risk of presenting seizure. Only 4 patients had early seizures and none had late seizures. At 6 months, 10 patients died and 73 patients had complete recovery. Seizures were not associated with death (P = 1.00) and 6-month functional outcome (P = 0.66). Conclusion: About half the patients with CVST had presenting seizures which was independently related to supratentorial lesion. However, seizures were not related to death or 6-month outcome.
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were noted. The presenting symptoms and the duration of illness were recorded. The presence of seizure, its type, duration, and frequency were noted. Status epilepticus was defined if the seizure lasted for more than 10 min. The seizures were categorized into presenting seizure (before the diagnosis of CVST), early seizure (within 14 days of diagnosis of CVST), and late seizure (after 14 days of diagnosis of CVST). Consciousness was assessed by Glasgow Coma Scale (GCS). The presence of cranial nerve palsy and papilloedema were noted. The muscle power was graded on a 0-5 Medical Research Council (MRC) scale, and muscle tone and tendon reflexes were also recorded. Co-ordination and sensation were tested in patients who could co-operate. The patients were investigated for underlying prothrombotic conditions and aetiology of CVST.
On MRI, the presence of supratentorial parenchymal lesions, their location (frontal, parietal, temporal or occipital) and type (pale or haemorrhagic infarction) were noted. On MRV, the location and extent of thrombosis and the number of sinuses affected were noted. The direct evidences of cerebral vein and sinus thrombosis on MRI were also considered in the diagnosis of CVST.
Treatment
Patients were treated with low molecular weight heparin or unfractionated heparin for 14 days followed by oral anticoagulant, and their International Normalized Ratio (INR) was maintained between 2 and 3. Patients with seizure were treated with AED, and those with status epilepticus were treated with intravenous lorazepam.
Outcome
Occurrence of early and late seizures was noted and recurrence of seizure was also recorded. The hospital mortality and its causes were recorded. Patients were followed up at 3, 6 and 12 months and their seizures and functional outcome were noted. The functional outcome was categorized on the basis of Barthel Index (BI) score into poor (BI < 12), partial (BI = 13-19), and complete (BI = 20) recovery. 4 BI was used for assessing the functional outcome as it evaluates 10 domains of activities of daily living which include feeding, grooming, bowel, bladder, bed to chair transfer, dressing, mobility, bathing, toilet, and climbing stairs.
Statistical analysis
The baseline characteristics of the patients with and without presenting seizure were compared by Chi square or independent t test. The predictors of presenting seizure were evaluated by univariate analysis including the demographic (gender, age), clinical (headache, vomiting, focal neurological deficit, papilloedema, GCS score), aetiology, number of risk factors, MRI findings (supratentorial lesion, location of lesion, haemorrhagic vs. nonhaemorrhagic infarction), and MRV findings (superficial or deep sinus, cortical veins and number of sinuses involved). The variables having a two tailed P-value of <0.10 on univariate analysis were included in the multivariate analysis. The patients who left hospital due to deteriorating clinical conditions were included in death group in the statistical analysis. At 6 months, the patients who died in hospital or during the follow-up and those lost to follow-up were included in the poor recovery group in the statistical analysis. The relationships of death and 6-month outcomes with presenting seizure were evaluated by Chi square test with Yates correction. The statistical analysis was done using SPSS for Windows version 16.0 (SPSS, Chicago, IL, USA) or Epi-Info version 6.04 (CDC, Atlanta, GA, USA) and the variable was considered significant if the two-tailed P-value was 0.05.
Results
Our results are based on 90 patients with CVST whose median age was 30 (range: 6-76) years and 48 (53.3%) patients were females. A total of 42 (46.7%) patients had presenting seizure and 4 (4.4%) had early seizure. The seizures were categorized as focal (n = 11), focal with secondary generalized (n = 19), and generalized tonic clonic (n = 16). There were 10 patients with generalized convulsive status epilepticus, and the remaining (n = 36) had discrete seizure with a frequency of seizure ranging between 1 and 4. Cranial MRI revealed infarction in 63 (70%) patients of which 45 patients had haemorrhagic changes. MRV revealed involvement of superficial sinuses (n = 77); deep sinuses (n = 5), and both (n = 8). Cortical vein thrombosis was noted in 4 patients.
Predictors of seizure
According to the univariate analysis, vomiting was significantly related to presenting seizure (P = 0.04). Age (P = 0.70), gender (P = 0.97), duration of illness (P = 0.13), headache (P = 1.0), papilloedema (P = 0.1), GCS score <9 (P = 0.99), underlying aetiology (P = 0.17), focal neurological deficit (P = 0.06), and death (P = 1.0) were not related to presenting seizure. The supratentorial parenchymal lesion (P = 0.005), haemorrhagic infarction (P = 0.002) and frontal lobe (P = .0.02) and parietal (P = 0.04) lobe involvement on MRI were significantly related to presenting seizure but the site of thrombosis and number of sinuses involved were not. The details are summarized in Table 1 . On multivariate analysis, the supratentorial parenchymal lesion on MRI (odds ratio [OR] = 4.67, 95% confidence interval [CI] 1.51-15.08, P = 0.005) was independently associated with presenting seizure. It was observed that the frequency of seizure recurrence during hospital stay (21/42, 50%) was higher in patients with presenting seizure than in patients with early seizure (1/4, 25%, P = 0.61).
Among patients with presenting or early seizure (n = 46), 4 patients died in the hospital, while among patients without seizures (n = 44), 2 patients died. Three patients (one with and two without seizure) left hospital due to deteriorating clinical conditions and they were included in death group in the statistical analysis. One patient died after hospital discharge. Death was not related to presenting seizure (P = 1.00) or early seizure (P = 1.00). None of the patients with status epilepticus died (P = 0.58). At 3 months, the survivors showed complete (n = 71), partial (n = 3) and poor (n = 6) recovery, while one patient was lost to follow-up. At 6 months, only 6 patients had poor and the remaining had complete recovery, and one patient was lost to follow-up ( Table 2) . The outcome at 6 months was also not different in the patients with presenting or early seizure compared to those without (P = 0.79).
During the 12 month follow-up, 5 patients had recurrent seizures; of these, 4 patients had been earlier diagnosed with presenting seizure and one patient with early seizure; no patient had late seizure. In one patient, seizure recurrence was due to drug default. Of these 5 patients, 4 had supratentorial lesion. The location of parenchymal lesion was not significantly different in the patients with and without late recurrence of seizure.
Discussion
In this retrospective analysis, 46.7% patients with CVST had presenting seizure, 4.4% had early seizure and none had late seizure; but, 5.6% had late recurrence of seizure. The frequency of seizures was significantly higher in the patients with supratentorial lesion, especially with the haemorrhagic lesion in frontoparietal region. Seizures in CVST are more commonly reported in neonates (71%) and children (48%), as compared to adults (37%). 5, 6 In our study, the age was not related to seizures which may be due to fewer children in this cohort. The clinical variables and the aetiology of CVST were also not related to presenting seizure. An earlier study, however, reported sensory motor deficit, aphasia and depth of coma, as predictors of seizure. 2 In the present study, the supratentorial lesion was associated with more than 4.67 times higher risk of seizure. This is in agreement with a multicentre study of CVST in which supratentorial lesion was associated with 4.92 times higher risk of presenting seizure. However, the significance of involvement of different cerebral regions was not reported. 7 In our study, though frontal and parietal lobe lesions were associated with significantly higher risk of presenting seizure by univariate analysis. Bousser and Russel reported that seizures are more frequent if the lesions are located anterior to the central sulcus and in patients with focal deficit. 8 The mechanism of seizure in haemorrhagic lesion is not well understood. Blood metabolites such as haemosiderin may cause focal cerebral irritation leading to seizure as reported in traumatic brain injury and animal experiment. 9, 10 In a recent report, the risk of acute symptomatic seizure was 2.7 times higher in haemorrhagic infarction compared to pale infarction. Total anterior circulation infarctions carried the highest risk of seizure (10.7%) compared to posterior circulation infarction (4.7%). Mortality rate observed in patients with seizure (12.5%) was higher than that observed in patients without seizure (6.3%). 11 A multicentre study on CVST also revealed higher deaths and dependency in the patients with seizure (26%) compared to those without seizure (14.8%). 7 In our study, however, death was not related to presenting seizure. This difference may be due to smaller sample size, difference in patient population, and tertiary care single centre study with uniform treatment protocol used in our study. The higher frequency of seizure has been reported in the patients with straight sinus or cerebral vein thrombosis. 7 In our study, the majority of patients (56.6%) had more than one sinus involvement and presenting seizure was not related to number of sinuses involved, as well as to the location of thrombosis. In this study, no patient had late seizure although seizure recurred in 5 patients who had either presenting (4 patients) or early seizure (1 patient). All our patients with presenting and early seizures received AEDs and none without seizures were on AED. In a study, 9.5% of patients had late seizure, especially those with early symptomatic seizure, and haemorrhagic lesions on CT or MRI. 12 In our study, only 5.6% of patients had late recurrence of seizure and it was not related to location of MRI lesion. The lower frequency of late recurrence of seizure in our study may be due to the use of AED in all the patients who had presenting or early seizures, whereas in an earlier study, 10% of patients did not receive AED in spite of having early seizures. 12 In our study, presenting and early seizures were not related to the late recurrences although a previous study have reported the correlation of early seizure with the late recurrences. 12 The 6-month outcome of our patients was not related to presenting or early seizures. All the patients with status epilepticus also survived. These results are in agreement with the International Study on Cerebral Vein and Dural Sinus Thrombosis cohort, in whom seizure was not an independent predictor of death or dependency. 13 
Conclusion
About half the patients with CVST had either presenting or early seizures. The patients with haemorrhagic supratentorial lesion involving the frontoparietal region are more likely to have seizure. a Include deaths during hospitalization (n = 6) and patients who left hospital due to deteriorating clinical condition (n = 3). b Includes deaths during hospitalization (n = 6); deaths after hospital discharge (n = 1); patients who left hospital due to deteriorating clinical condition (n = 3), dependency (n = 6), and lost to follow-up (n = 1). CVST, cerebral venous sinus thrombosis.
The presence of seizure, however, is not a predictor of death or disability at 6 months.
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